chartexchange

Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger

PR Newswire | Nov 17, 2026 8:05 AM EST

Merger with Eos SENOLYTIX expected to close by end of the year FRAMINGHAM, Mass., Nov. 17, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix", the "Company" or "our") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products...

Read original article